| Judge Consulting Group President and CTO John Battaglia Named to City & State PA’s 2026 “40 in Their 40s” List |
Globe Newswire |
07/28 |
07:26 |
| DCX’s DexTrader Announces Upgrade, Targeting On-Chain Yield-Bearing Collateralized Derivatives Data Services Segment |
Globe Newswire |
07/28 |
07:18 |
| Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance |
Globe Newswire |
07/28 |
07:00 |
| Blue Gold Announces Appointment of Andrew Cavaghan as Chairman |
Globe Newswire |
07/28 |
07:00 |
| Westhaven Reports South Zone Resource Infill Drilling Continues to Confirm Continuity of High-Grade Gold and Silver Mineralization Including 27.51m Grading 14.47 g/t Au & 52 g/t Ag Shovelnose Gold Property, Southern British Columbia |
Globe Newswire |
07/28 |
07:00 |
| Selkirk Copper Mines Inc. Begins Trading on OTCQX Best Market |
Globe Newswire |
07/28 |
07:00 |
| Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder |
Globe Newswire |
07/28 |
07:00 |
| Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026 |
Globe Newswire |
07/28 |
07:00 |
| Lungpacer Announces Health Economic Analysis Demonstrating Clinical and Cost Benefits of AeroPace in Mechanically Ventilated Patients |
Globe Newswire |
07/28 |
07:00 |
| Antag Therapeutics Announces Dosing of First Patient in Phase 2a Trial of First-in-Class GIPR Antagonist AT7687 |
Globe Newswire |
07/28 |
07:00 |
| Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML |
Globe Newswire |
07/28 |
07:00 |
| Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026 |
Globe Newswire |
07/28 |
07:00 |
| Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus |
Globe Newswire |
07/28 |
07:00 |
| Factorial Sets Date for Second Quarter 2026 Results |
Globe Newswire |
07/28 |
07:00 |
| VR Confirms New IP and Conductivity Anomalies on its Bonita Property Porphyry Copper-Gold Project in Nevada |
Globe Newswire |
07/28 |
07:00 |
| NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026 |
Globe Newswire |
07/28 |
07:00 |
| National Civil Rights Museum Hosts the 2026 Ruby Bridges Reading Festival |
Globe Newswire |
07/28 |
07:00 |
| SunPower Reports Q2’26 Results |
Globe Newswire |
07/28 |
07:00 |
| DoubleDown Interactive to Report 2026 Second Quarter Results on August 11 and Host Conference Call and Webcast |
Globe Newswire |
07/28 |
07:00 |
| YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs |
Globe Newswire |
07/28 |
06:55 |
| INNIO wins 1.1 Gigawatt Gas Engine Order for Major Data Center Campus |
Globe Newswire |
07/28 |
06:46 |
| MEXC Users Put Nearly a Third of First-Month RealStocks Volume Into SpaceX |
Globe Newswire |
07/28 |
06:44 |
| INNIO Group Reports Second Quarter 2026 Financial Results |
Globe Newswire |
07/28 |
06:31 |
| Bimergen Energy Emerges With $8.9 Million Revenue Transaction |
Globe Newswire |
07/28 |
06:30 |
| Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs |
Globe Newswire |
07/28 |
06:30 |
